期刊文献+

溶液粘度影响聚合物角膜滞留时间的体外评价 被引量:4

EFFECT OF SOLUTION VISCOSITY ON POLYMER PRECORNEAL RESIDENCE TIME EVALUATED BY IN VITRO METHOD
下载PDF
导出
摘要 目的 比较水溶性聚合物的角膜滞留能力 ,评价溶液粘度对其角膜滞留时间的影响 ,为眼用液体制剂的处方设计提供参考。方法 用束缚泡技术 ,以接触角的连续变化为指征 ,在模拟生理条件下考察聚合物从离体眼球表面解吸附的动力学过程。结果 卡波姆、透明质酸钠 (HA)、羟丙基甲基纤维素、聚乙烯醇和羧甲基纤维素钠 (CMC Na)的角膜滞留能力有显著差异 ,其中卡波姆和HA吸附于离体眼球表面达 15min以上 ,显示出较好的生物粘附性。溶液粘度由 12mPa·s增大至 5 0mPa·s,卡波姆和HA的角膜滞留时间分别延长 10min和 7min ,而CMC Na的角膜滞留时间未受影响。结论 体外实验结果表明 ,适当提高溶液粘度能够延长生物粘附性聚合物在角膜表面的滞留时间。 AIM To evaluate how solution viscosity affects the precorneal residence of five water soluble polymers with different properties. METHODS Captive bubble technique was used, with the consecutive change of contact angle interpreted as an indication of desorption process, to study the residence of those polymers in vitro on freshly enucleated rabbit eyes under physiological conditions. RESULTS Carbopol and sodium hyaluronate (HA), which adsorbed to isolated ocular surface more than 15 min, showed the optimum precorneal retentive capabilities. When the solution viscosity increased from 12 mPa·s to 50 mPa·s, the residence time of carbopol and HA were prolonged 10 min and 7 min, respectively, but that of sodium carboxymethylcellulose was not affected. CONCLUSION The result suggested that higher viscosity is beneficial to improve the ocular residence time of bio adhesive polymers.
出处 《药学学报》 CAS CSCD 北大核心 2002年第6期469-472,共4页 Acta Pharmaceutica Sinica
关键词 水溶性聚合物 角膜滞留 溶液粘度 接触角 液体制剂 water soluble polymer precorneal residence solution viscosity contact angle
  • 相关文献

参考文献13

  • 1Greaves JL, Wilson CG. Treatment of diseases of the eye with mucoadhesive delivery systems [J]. Adv Drug Deliv Rev, 1993,11(2):349-383.
  • 2Edsman K, Carlfors J, Petersson R. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use [J]. Eur J Pharm Sci, 1998,6(1):105-112.
  • 3Ludwig A, Unlü N, Van Ooteghem M. Evaluation of viscous ophthalmic vehicles containing carbomer by slit-lamp fluorophotometry in humans [J]. Int J Pharm, 1990,61(1):15-25.
  • 4Ludwig A, Van Ooteghem M. The evaluation of viscous ophthalmic vehicles by slit lamp fluorophotometry in humans [J]. Int J Pharm, 1989,54(2):95-102.
  • 5Saettone MF, Chetoni P, Torracca MT, et al. Evaluation of mucoadhesive properties and in vivo activity of ophthalmic vehicles based on hyaluronic acid [J]. Int J Pharm, 1989,51(2):203-212.
  • 6Felt O, Furrer P, Mayer JM, et al. Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention [J]. Int J Pharm, 1999,180(2):185-193.
  • 7Durrani AM, Farr SJ, Kellaway IW. Influence of molecular weight and formulation pH on the precorneal clearnce rate of hyaluronic acid in the rabbit eye [J]. Int J Pharm, 1995,118(2):243-250.
  • 8Meseguer G, Gurny R, Buri P, et al. Gamma scintigraphic study of precorneal drainage and assessment of miotic response in rabbits of various ophthalmic formulations containing pilocarpine [J]. Int J Pharm, 1993,95(2):229-234.
  • 9Zaki I, Fitzgerald P, Hardy JG, et al. A comparison of the effect of viscosity on the precorneal residence of solutions in rabbit and man [J]. J Pharm Pharmacol, 1986,38(4):463-466.
  • 10Shanker RM, Ahmed I, Bourassa PA, et al. An in vitro technique for measuring contact angles on the corneal surface and its application to evaluate corneal wetting properties of water soluble polymers [J]. Int J Pharm, 1995,119(2):149-163.

同被引文献65

  • 1刘高峰,刘艳,原晓峰.玻璃酸钠制剂研究进展及应用[J].中国生化药物杂志,2004,25(4):252-254. 被引量:20
  • 2凌沛学,张天民,李琦,荣晓花.玻璃酸在眼科药物中的应用与研究进展[J].中国药物与临床,2004,4(9):697-699. 被引量:5
  • 3姚静,周建平,平其能,卢韵,于力.类透明质酸壳聚糖微乳对小鼠血脑屏障通透性的影响[J].药学学报,2006,41(7):615-618. 被引量:12
  • 4Brown MB, Hanpanitchareen M, Martin GP. An in vitro investigation into the effect of glycosaminoglycans on the skin partitioning and deposition of NSAIDs [J]. Int J Pharm ,2001,225(1-2): 113.
  • 5Brown TJ, Alcorn D, Fraser JR. Absorption of hyaluronan applied to the surface of intact skin[J]. J Invest Dermatol, 1999,113(5) :740.
  • 6Alkrad JA, Mrestani Y, Neubert RHH.The release profiles of intact and enzymatically digested hyaluronic acid from semisolid formulations using multi-layer membrance system [ J ]. Eur J Pharm Biopharm,2003,56(1) :37.
  • 7Coradini D, Pellizzaro C, Miglierini G. Hyaluronic acid as drug delivery for sodium butyrate: improvement of the anti-proliferative activity on a breast-cancer cell line[J]. Int J Cancer, 1999,81 (3) :411.
  • 8Coradini D, Pellizzaro C, Abolafio G, et al. Hyaluronic-acid butyric esters as promising antineoplastic agents in human lung carcinoma: A preclinical study[ J]. J Controlled Release, 1998,50( 1-3 ): 167.
  • 9Luo Y, Ziebell MR, Prestwich GD.A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells[J]. Biomacromolecules, 2000, 1(2):208.
  • 10Kim A, Checkla DM, Dehazya P, et al. Characterization of DNA-hyaluronan matrix for sustained gene transfer [ J ]. J Controlled Release ,2003,90(1) :81.

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部